Activity

The US FDA Has Approved The First Long-Acting Injectable HIV PrEP Medication. The Drug, Called Apretude, Given To Patients Every 2 Months, Is Said To Be 69% More Effective Than The Daily HIV Prevention Pills, Like Truvada and Descovy, For Cisgender Men And Transgender Women Who Have Sex With Men, And 90% More Effective For Cisgender Women.

FDA approves first injectable HIV prevention drug

https://www.nbcnews.com/nbc-out/out-health-and-wellness/fda-approves-first-injectable-hiv-prevention-drug-rcna9426

The Food and Drug Administration has approved the first long-acting injectable medication for use as pre-exposure prevention, or PrEP, against HIV, the agency